US$ 23.98
when were glp 1 drugs invented Discovery of GLP-1–Based for the Treatment of Obesity A future Nobel Prize? Looking
Description
Metformin and the gastrointestinal tract
Weight loss was similar in patients on CSII, with a mean weight loss of 6.3 kg (55)

P-rank scores show that SGLT-2 inhibitors were ranked first in reducing nonfatal MI (90.4%) (Additional file 1: Table S2)

All this is to say that we would expect the prevalence of coverage of GLP-1s in the individual market to be quite low compared to the self-insured employer market